NOX2 control over energy metabolism plays a role in acute myeloid leukaemia prognosis and survival FREE RADICAL BIO MED
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma Front Oncol
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature LEUKEMIA LYMPHOMA
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors Front Immunol
Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia Transl Pediatr
Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center LEUKEMIA LYMPHOMA
Protein features instruct the secretion dynamics from metal-supported synthetic amyloids Int J Biol Macromol
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial Lancet Haematol